Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Eli Lilly, Zepbound

Digest more
 · 17h · on MSN
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound
Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.

Continue reading

 · 14h · on MSN
A new generation of weight-loss drugs is getting closer to patients. Here’s how they differ from Wegovy and Zepbound.
 · 11h · on MSN
Lose weight on Zepbound, keep it off with Eli Lilly’s new pill? Data say that works.
BioPharma Dive
11h

Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial

Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...
STAT
18h

Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow

Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
AOL
2mon

Zepbound vs. Wegovy: Comparing weight loss drugs

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms